Showing results (181-190 of 1,028) with videos related to

Sort By:
Pageof 103
The Lancet. Respiratory Medicine|December 4, 2014
Mortality prediction in intensive care units with the Super ICU Learner Algorithm (SICULA): a population-based studyRomain Pirracchio, Maya L Petersen, Marco Carone, et al.
The Lancet. Respiratory Medicine|December 4, 2014
Incidence of mortality and morbidity related to postoperative lung injury in patients who have undergone abdominal or thoracic surgery: a systematic review and meta-analysisAry Serpa Neto, Sabrine N T Hemmes, Carmen S V Barbas, et al.
The Lancet. Respiratory Medicine|December 20, 2014
Individualised oxygen delivery targeted haemodynamic therapy in high-risk surgical patients: a multicentre, randomised, double-blind, controlled, mechanistic trialGareth L Ackland, Sadaf Iqbal, Laura Gallego Paredes, et al.
The Lancet. Respiratory Medicine|July 11, 2014
Immune mechanisms and development of childhood asthmaDiana Raedler, Bianca Schaub
The Lancet. Respiratory Medicine|August 25, 2014
Respiratory infections in patients undergoing mechanical ventilationJordi Rello, Thiago Lisboa, Despoina Koulenti
The Lancet. Respiratory Medicine|October 13, 2014
Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging studyMario Castro, Sally E Wenzel, Eugene R Bleecker, et al.
The Lancet. Respiratory Medicine|December 2, 2014
Cognitive decline after sepsisDjillali Annane, Tarek Sharshar
The Lancet. Respiratory Medicine|December 3, 2014
The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trialGeraint B Rogers, Kenneth D Bruce, Megan L Martin, et al.
The Lancet. Respiratory Medicine|January 13, 2018
Induced hypothermia in patients with septic shock and respiratory failure (CASS): a randomised, controlled, open-label trialTheis Skovsgaard Itenov, Maria Egede Johansen, Morten Bestle, et al.
The Lancet. Respiratory Medicine|May 19, 2018
Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 studyLuana Calabrò, Aldo Morra, Diana Giannarelli, et al.
Pageof 103